• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定阿联酋人 CYP2D6 基因中的新等位基因,并确定等位基因和基因型频率。

Identification of new alleles and the determination of alleles and genotypes frequencies at the CYP2D6 gene in Emiratis.

机构信息

Department of Pharmacology, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emirates.

出版信息

PLoS One. 2011;6(12):e28943. doi: 10.1371/journal.pone.0028943. Epub 2011 Dec 22.

DOI:10.1371/journal.pone.0028943
PMID:22216145
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3245235/
Abstract

CYP2D6 belongs to the cytochrome P450 superfamily of enzymes and plays an important role in the metabolism of 20-25% of clinically used drugs including antidepressants. It displays inter-individual and inter-ethnic variability in activity ranging from complete absence to excessive activity which causes adverse drug reactions and toxicity or therapy failure even at normal drug doses. This variability is due to genetic polymorphisms which form poor, intermediate, extensive or ultrarapid metaboliser phenotypes. This study aimed to determine CYP2D6 alleles and their frequencies in the United Arab Emirates (UAE) local population. CYP2D6 alleles and genotypes were determined by direct DNA sequencing in 151 Emiratis with the majority being psychiatric patients on antidepressants. Several new alleles have been identified and in total we identified seventeen alleles and 49 genotypes. CYP2D61 (wild type) and CYP2D62 alleles (extensive metaboliser phenotype) were found with frequencies of 39.1% and 12.2%, respectively. CYP2D641 (intermediate metaboliser) occurred in 15.2%. Homozygous CYP2D64 allele (poor metaboliser) was found with a frequency of 2% while homozygous and heterozygous CYP2D64 occurred with a frequency of 9%. CYP2D62xn, caused by gene duplication (ultrarapid metaboliser) had a frequency of 4.3%. CYP2D6 gene duplication/multiduplication occurred in 16% but only 11.2% who carried more than 2 active functional alleles were considered ultrarapid metabolisers. CYP2D6 gene deletion in one copy occurred in 7.5% of the study group. In conclusion, CYP2D6 gene locus is heterogeneous in the UAE national population and no significant differences have been identified between the psychiatric patients and controls.

摘要

CYP2D6 属于细胞色素 P450 超家族的酶,在 20-25%的临床使用药物的代谢中发挥重要作用,包括抗抑郁药。它在个体间和种族间的活性存在差异,从完全缺乏到过度活跃,这会导致不良反应和毒性或治疗失败,即使在正常药物剂量下也是如此。这种变异性是由于遗传多态性引起的,这些遗传多态性形成了不良、中间、广泛或超快代谢表型。本研究旨在确定阿拉伯联合酋长国(阿联酋)当地人群中的 CYP2D6 等位基因及其频率。通过直接 DNA 测序在 151 名阿联酋人(其中大多数是服用抗抑郁药的精神病人)中确定了 CYP2D6 等位基因和基因型。已经确定了几种新的等位基因,总共确定了 17 个等位基因和 49 种基因型。CYP2D61(野生型)和 CYP2D62 等位基因(广泛代谢表型)的频率分别为 39.1%和 12.2%。CYP2D641(中间代谢表型)的发生率为 15.2%。纯合 CYP2D64 等位基因(弱代谢表型)的频率为 2%,而纯合和杂合 CYP2D64 的频率为 9%。由基因重复(超快代谢表型)引起的 CYP2D62xn 的频率为 4.3%。CYP2D6 基因重复/多倍体发生在 16%,但只有 11.2%携带超过 2 个活性功能等位基因的人被认为是超快代谢者。研究组中发生了 7.5%的 CYP2D6 基因缺失。总之,CYP2D6 基因座在阿联酋国民群体中是异质的,精神病人和对照组之间没有发现显著差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69c5/3245235/469290ca9593/pone.0028943.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69c5/3245235/469290ca9593/pone.0028943.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69c5/3245235/469290ca9593/pone.0028943.g001.jpg

相似文献

1
Identification of new alleles and the determination of alleles and genotypes frequencies at the CYP2D6 gene in Emiratis.鉴定阿联酋人 CYP2D6 基因中的新等位基因,并确定等位基因和基因型频率。
PLoS One. 2011;6(12):e28943. doi: 10.1371/journal.pone.0028943. Epub 2011 Dec 22.
2
Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population.意大利人群中CYP2C9、CYP2C19和CYP2D6的等位基因及基因型频率
Pharmacol Res. 2004 Aug;50(2):195-200. doi: 10.1016/j.phrs.2004.01.004.
3
Polymorphisms of CYP2C19 and CYP2D6 in Israeli ethnic groups.以色列不同种族群体中CYP2C19和CYP2D6的多态性。
Am J Pharmacogenomics. 2004;4(6):395-401. doi: 10.2165/00129785-200404060-00006.
4
Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.人类细胞色素P450 2D6的多态性及其临床意义:第一部分。
Clin Pharmacokinet. 2009;48(11):689-723. doi: 10.2165/11318030-000000000-00000.
5
CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population.阿什肯纳兹犹太人群体中CYP2C9、CYP2C19和CYP2D6等位基因频率
Pharmacogenomics. 2007 Jul;8(7):721-30. doi: 10.2217/14622416.8.7.721.
6
Failure to respond to treatment with typical antipsychotics is not associated with CYP2D6 ultrarapid hydroxylation.对典型抗精神病药物治疗无反应与CYP2D6超快速羟基化无关。
Br J Clin Pharmacol. 1999 Sep;48(3):388-94. doi: 10.1046/j.1365-2125.1999.00006.x.
7
Polymorphisms in CYP2D6 duplication-negative individuals with the ultrarapid metabolizer phenotype: a role for the CYP2D6*35 allele in ultrarapid metabolism?具有超快代谢者表型的CYP2D6基因重复阴性个体中的多态性:CYP2D6*35等位基因在超快代谢中的作用?
Pharmacogenetics. 2001 Feb;11(1):45-55. doi: 10.1097/00008571-200102000-00006.
8
Prevalence of the CYP2D6*10 (C100T), *4 (G1846A), and *14 (G1758A) alleles among Iranians of different ethnicities.不同种族伊朗人群中CYP2D6*10(C100T)、*4(G1846A)和*14(G1758A)等位基因的流行率。
Drug Des Devel Ther. 2015 May 13;9:2627-34. doi: 10.2147/DDDT.S79709. eCollection 2015.
9
Effect of CYP2D6 genotype on exposure and efficacy of risperidone and aripiprazole: a retrospective, cohort study.CYP2D6基因对利培酮和阿立哌唑暴露量及疗效的影响:一项回顾性队列研究。
Lancet Psychiatry. 2019 May;6(5):418-426. doi: 10.1016/S2215-0366(19)30088-4. Epub 2019 Apr 15.
10
CYP2D6 and CYP2C19 genotypes of patients with terodiline cardiotoxicity identified through the yellow card system.通过黄卡系统识别出的特罗地林心脏毒性患者的CYP2D6和CYP2C19基因型。
Br J Clin Pharmacol. 2000 Jul;50(1):77-80. doi: 10.1046/j.1365-2125.2000.00230.x.

引用本文的文献

1
Pharmacogenetic Approach to Tramadol Use in the Arab Population.阿位伯人群中曲马多使用的遗传药理学方法。
Int J Mol Sci. 2024 Aug 16;25(16):8939. doi: 10.3390/ijms25168939.
2
Utilizing Pharmacogenomic Data for a Safer Use of Statins among the Emirati Population.利用药物基因组学数据提高阿联酋人群使用他汀类药物的安全性。
Curr Vasc Pharmacol. 2024;22(3):218-229. doi: 10.2174/0115701611283841231227064343.
3
genetic polymorphisms in Saudi systemic lupus erythematosus patients: A cross-sectional study.沙特系统性红斑狼疮患者的遗传多态性:一项横断面研究。

本文引用的文献

1
Frequency of five important CYP2D6 alleles within an Iranian population (Eastern Azerbaijan).伊朗人群(东阿塞拜疆省)中五个重要CYP2D6等位基因的频率
Genet Test Mol Biomarkers. 2009 Oct;13(5):665-70. doi: 10.1089/gtmb.2009.0009.
2
CYP2D6 genotyping for functional-gene dosage analysis by allele copy number detection.通过等位基因拷贝数检测进行CYP2D6基因分型以进行功能基因剂量分析。
Clin Chem. 2009 Aug;55(8):1546-54. doi: 10.1373/clinchem.2009.123620. Epub 2009 Jun 18.
3
Novel variants of major drug-metabolising enzyme genes in diverse African populations and their predicted functional effects.
Saudi Med J. 2023 Mar;44(3):237-245. doi: 10.15537/smj.2023.44.3.20220581.
4
Frequencies of CYP2D6 genetic polymorphisms in Arab populations.阿拉伯人群 CYP2D6 基因多态性的频率。
Hum Genomics. 2022 Feb 5;16(1):6. doi: 10.1186/s40246-022-00378-z.
5
Population pharmacogenomics: an update on ethnogeographic differences and opportunities for precision public health.群体药物基因组学:种族地理差异及精准公共卫生的机遇更新。
Hum Genet. 2022 Jun;141(6):1113-1136. doi: 10.1007/s00439-021-02385-x. Epub 2021 Oct 15.
6
Association of single nucleotide polymorphisms of cytochrome P450 enzymes with experience of vasomotor, vaginal and musculoskeletal symptoms among breast cancer patients: a systematic review.细胞色素 P450 酶单核苷酸多态性与乳腺癌患者血管舒缩、阴道和肌肉骨骼症状体验的关联:系统评价。
BMC Cancer. 2021 May 18;21(1):570. doi: 10.1186/s12885-021-08268-8.
7
Variation in 100 relevant pharmacogenes among emiratis with insights from understudied populations.阿联酋人群中 100 个相关药物基因的变异及来自研究较少人群的见解。
Sci Rep. 2020 Dec 4;10(1):21310. doi: 10.1038/s41598-020-78231-3.
8
Distribution of polymorphism in the Middle Eastern region.中东地区多态性的分布。
J Res Med Sci. 2019 Jul 24;24:61. doi: 10.4103/jrms.JRMS_1076_18. eCollection 2019.
9
Assessment of Dapagliflozin Effectiveness as Add-on Therapy for the Treatment of Type 2 Diabetes Mellitus in a Qatari Population.评估达格列净作为附加疗法治疗卡塔尔人群 2 型糖尿病的疗效。
Sci Rep. 2019 May 3;9(1):6864. doi: 10.1038/s41598-019-43052-6.
10
The Genetic Variation of CYP2D6 Gene in the Bosnian Population.波斯尼亚人群中CYP2D6基因的遗传变异
Med Arch. 2018 Dec;72(6):396-400. doi: 10.5455/medarh.2018.72.396-400.
不同非洲人群中主要药物代谢酶基因的新型变体及其预测的功能影响。
Hum Genomics. 2009 Jan;3(2):169-90. doi: 10.1186/1479-7364-3-2-169.
4
CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure.细胞色素P450 2D6的全球基因变异显示,活性改变的变异体频率很高,且不存在大陆结构差异。
Pharmacogenet Genomics. 2007 Feb;17(2):93-101. doi: 10.1097/01.fpc.0000239974.69464.f2.
5
Impaired expression of CYP2D6 in intermediate metabolizers carrying the *41 allele caused by the intronic SNP 2988G>A: evidence for modulation of splicing events.内含子单核苷酸多态性2988G>A导致携带*41等位基因的中间代谢者中CYP2D6表达受损:剪接事件调控的证据。
Pharmacogenet Genomics. 2006 Oct;16(10):755-66. doi: 10.1097/01.fpc.0000230112.96086.e0.
6
Interethnic differences in genetic polymorphisms of CYP2D6 in the U.S. population: clinical implications.美国人群中CYP2D6基因多态性的种族间差异:临床意义。
Oncologist. 2006 Feb;11(2):126-35. doi: 10.1634/theoncologist.11-2-126.
7
Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19.精神科医生使用CYP450 2D6和CYP450 2C19药物基因检测的临床指南。
Psychosomatics. 2006 Jan-Feb;47(1):75-85. doi: 10.1176/appi.psy.47.1.75.
8
A pharmacogeneticist's look at drug effects and the drug development process: an overview.药物遗传学家对药物效应及药物研发过程的审视:概述
Expert Opin Pharmacother. 2005 Jul;6(8):1299-303. doi: 10.1517/14656566.6.8.1299.
9
Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity.细胞色素P450 2D6(CYP2D6)的基因多态性:临床后果、进化方面及功能多样性
Pharmacogenomics J. 2005;5(1):6-13. doi: 10.1038/sj.tpj.6500285.
10
Moving towards individualized medicine with pharmacogenomics.借助药物基因组学迈向个性化医疗。
Nature. 2004 May 27;429(6990):464-8. doi: 10.1038/nature02626.